Dana-Farber at Faulkner Hospital

Boston, Massachusetts 02130

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Carcinoma of the Breast

Studies at this site

• Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer — Completed
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer — Completed
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer — Completed
• A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer — Completed